|
|
S&P Pharmaceutical Company Limited - Comparative Business Analysis Snapshot
Business Description
S&P Pharmaceutical Company Limited Formerly known as S&P Pharmaceutical Industry Company Limited. The Group's principal activities are the research, development, manufacture and sale of Chinese, OTC drugs and Tibetan medicines and health products. Other activities include the wholesale and retail of Chinese and biological products. These products are for cardiovascular and respiratory systems in the form of solutions and capsules. Products include Chongcaojing (an essence made from Chinese caterpillar fungus), Chongcao Shensi oral liquid, Yiganjian (hepatitis medicine) and Xinnaoxin (Tibetan medicine for diseases caused by shortage of oxygen), among others. Operations of the Group are carried out in the People's Republic of China.
Competitor Analysis
This analysis compares S&P Pharmaceutical Company Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
